Paul Latkany, MD
The purpose of this study is to examine the efficacy and safety data in patients with intermediate, pan-, or posterior uveitis, comparing systemic therapy vs. Fluocinolone Acetonide (FA) Implant. Primary end point is Visual Acuity.
Contact Principal Investigator
Principal Investigator: Paul Latkany, MD at (212) 687-0265
Home > Current Research > Clinical Trials in Ophthalmology > Multicenter Uveitis Steroid Treatment Trial (MUST)